Momentum Intensifies To Enhance Oversight Of Lab-Produced Genetic Tests
This article was originally published in The Gray Sheet
Executive Summary
Calls to beef up regulations impacting genetic tests fashioned by clinical laboratories are getting louder, with particular emphasis on augmenting FDA's oversight role